Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.
2.
3.

[Frontier of mycobacterium research--host vs. mycobacterium].

Okada M, Shirakawa T.

Kekkaku. 2005 Sep;80(9):613-29. Japanese.

PMID:
16245793
4.

Gp130 signaling promotes development of acute experimental colitis by facilitating early neutrophil/macrophage recruitment and activation.

Sander LE, Obermeier F, Dierssen U, Kroy DC, Singh AK, Seidler U, Streetz KL, Lutz HH, Müller W, Tacke F, Trautwein C.

J Immunol. 2008 Sep 1;181(5):3586-94.

5.

Interleukin-6 trans-signalling in chronic inflammation and cancer.

Scheller J, Ohnesorge N, Rose-John S.

Scand J Immunol. 2006 May;63(5):321-9. Review.

6.

Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways.

Yu J, Mookherjee N, Wee K, Bowdish DM, Pistolic J, Li Y, Rehaume L, Hancock RE.

J Immunol. 2007 Dec 1;179(11):7684-91.

7.

Role of interleukin-13 in innate and adaptive immunity.

Brubaker JO, Montaner LJ.

Cell Mol Biol (Noisy-le-grand). 2001 Jun;47(4):637-51. Review.

PMID:
11502071
8.

The IL-6/sIL-6R complex as a novel target for therapeutic approaches.

Rose-John S, Waetzig GH, Scheller J, Grötzinger J, Seegert D.

Expert Opin Ther Targets. 2007 May;11(5):613-24. Review.

PMID:
17465721
9.

Interleukin-6 and its receptor: from bench to bedside.

Scheller J, Rose-John S.

Med Microbiol Immunol. 2006 Dec;195(4):173-83. Epub 2006 May 31. Review.

PMID:
16741736
10.

Cutting edge: trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+CD25 T cells.

Dominitzki S, Fantini MC, Neufert C, Nikolaev A, Galle PR, Scheller J, Monteleone G, Rose-John S, Neurath MF, Becker C.

J Immunol. 2007 Aug 15;179(4):2041-5.

11.

Innate cellular immune responses in newborns.

Maródi L.

Clin Immunol. 2006 Feb-Mar;118(2-3):137-44. Epub 2005 Dec 27. Review.

PMID:
16377252
12.

Interleukin 5 in the link between the innate and acquired immune response.

Takatsu K, Kouro T, Nagai Y.

Adv Immunol. 2009;101:191-236. doi: 10.1016/S0065-2776(08)01006-7. Review.

PMID:
19231596
13.

Leukocytes in glomerular injury.

Holdsworth SR, Tipping PG.

Semin Immunopathol. 2007 Nov;29(4):355-74. Epub 2007 Oct 16. Review.

PMID:
17938927
14.

Interleukin-6 and chronic inflammation.

Gabay C.

Arthritis Res Ther. 2006;8 Suppl 2:S3. Epub 2006 Jul 28. Review.

15.

Recent insights into the role of host innate and acquired immunity responses.

Liu P, Fuse K, Chu G, Liu Y, Opavsky A.

Ernst Schering Res Found Workshop. 2006;(55):123-39. Review.

PMID:
16329661
16.

TWEAK attenuates the transition from innate to adaptive immunity.

Maecker H, Varfolomeev E, Kischkel F, Lawrence D, LeBlanc H, Lee W, Hurst S, Danilenko D, Li J, Filvaroff E, Yang B, Daniel D, Ashkenazi A.

Cell. 2005 Dec 2;123(5):931-44.

17.

Regulation of airway innate and adaptive immune responses: the IL-17 paradigm.

Hung LY, Velichko S, Huang F, Thai P, Wu R.

Crit Rev Immunol. 2008;28(4):269-79. Review.

PMID:
19166380
18.

Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease.

Rose-John S, Mitsuyama K, Matsumoto S, Thaiss WM, Scheller J.

Curr Pharm Des. 2009;15(18):2095-103. Review.

PMID:
19519447
19.

Innate and acquired immunity and epithelial cell function in chronic rhinosinusitis.

Schleimer RP, Lane AP, Kim J.

Clin Allergy Immunol. 2007;20:51-78. Review.

PMID:
17534045
20.

Interleukin-17: a novel inflammatory cytokine that bridges innate and adaptive immunity.

Yu JJ, Gaffen SL.

Front Biosci. 2008 Jan 1;13:170-7. Review.

PMID:
17981535

Supplemental Content

Support Center